REGULATORY

Chuikyo Member Prods MHLW to Present Data on Savings through Generic Use

April 28, 2016

- Only subscribers can save articles.
  
  Sign In
  
  Subscribe

A member of the health ministry’s Central Social Insurance Medical Council (Chuikyo) on April 27 called for data to be presented on how much savings in medical costs have been brought on by the use of generics. At the day’s…

To read the full story

Chuikyo OKs 7 Drugs Subject to Cost-Effective Review; Re-Pricing to Be Conducted in 2018
April 27, 2016

REGULATORY

LDP, Ishin Call for Proper Valuation in CEA Scheme at Reform Talks
April 3, 2026
MHLW Revises Biological Raw Material Rules, Clarifies Donor Testing Flexibility
April 2, 2026
Japan Officially Eases Trial Recruitment Rules; Industry Welcomes Move
April 1, 2026
MHLW Updates Q&A on Use of Registry Data in Drug Applications
April 1, 2026
Japan Panel Designates Two Ebola Therapies for Early Approval Pathway
April 1, 2026

Chuikyo Debate on FY2026 Drug Pricing Reform

Chuikyo OKs New CEA Handling, with Third-Party Verification Ahead

Japan’s cost-effectiveness assessment (CEA) panel has approved a revised handling policy for the CEA system for FY2026, with the health…

COMMENTARY

Japan’s FY2026 R&D Tax Credit Reform Wins Broad Industry Backing

By Sakura Kono

Japan will overhaul its R&D tax credit regime in its FY2026 reform, introducing a new strategic category alongside existing frameworks.…

COLUMN

Strategic Talent Acquisition in the Japanese Life Sciences Sector: Your Market Intelligence Briefing

By Philip Carrigan

Focus: How to Get the Talent You Need in a Tough MarketThe Japanese life sciences sector presents a challenging landscape for global companies. To succeed, you must move beyond reactive hiring and adopt a truly strategic talent acquisition model. Our…